News & Events

Roundtable: Aseptic Manufacturing Trends

CEO of Symbiosis Pharmaceutical Services, Colin Mackay, was recently invited to participate in a roundtable discussion on aseptic manufacturing trends for Contract Pharma along with leaders from Recipharm and ChargePoint Technology.

The resulting article explores key trends and challenges when it comes to aseptic manufacturing.

In the article, Colin explains: “The development of robust single-use manufacturing technology has been a step-change in the sector, enabling more efficient fill finish activity. Rapid access to manufacturing slots and quick turnaround times are critical factors for our customers when selecting a contract partner and single-use technology is one reason that we can offer this level of service. We have also witnessed a continued drive towards outsourcing due to the specialized nature of some of the manufacturing challenges that companies are facing.”

You can read the full discussion here, via Contract Pharma.

Find out more about our aseptic contract manufacturing services.

Get In Touch.

By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.